Coexpression cluster:C1639

Full id: C1639_breast_small_left_adipose_cervix_thyroid_vagina

Phase1 CAGE Peaks

Hg19::chr11:62009704..62009716,+	p2@SCGB1D2
Hg19::chr11:62037622..62037637,+	p1@SCGB2A2
Hg19::chr1:10057278..10057296,+	p1@RBP7
Hg19::chr3:186575556..186575565,+	p@chr3:186575556..186575565 +
Hg19::chr3:186575653..186575676,+	p@chr3:186575653..186575676 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0019841	retinol binding	0.00600211739638302
GO:0016918	retinal binding	0.00600211739638302
GO:0005501	retinoid binding	0.00600211739638302
GO:0019840	isoprenoid binding	0.00600211739638302
GO:0005496	steroid binding	0.0239604357212903

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
CD14-positive, CD16-negative classical monocyte	2.12e-20	42
classical monocyte	1.65e-17	45
myeloid leukocyte	2.41e-15	76
monopoietic cell	1.62e-12	63
monocyte	1.62e-12	63
monoblast	1.62e-12	63
promonocyte	1.62e-12	63
myeloid lineage restricted progenitor cell	2.15e-12	70
granulocyte monocyte progenitor cell	1.62e-11	71
macrophage dendritic cell progenitor	1.82e-11	65

Uber Anatomy

Ontology term	p-value	n
adult organism	9.25e-45	115
organ	2.11e-15	511
neural plate	1.27e-12	86
presumptive neural plate	1.27e-12	86
multi-cellular organism	1.36e-12	659
embryo	1.44e-12	612
neural tube	2.13e-12	57
neural rod	2.13e-12	57
future spinal cord	2.13e-12	57
neural keel	2.13e-12	57
neurectoderm	8.31e-12	90
anatomical system	2.44e-11	625
anatomical group	3.76e-11	626
embryonic structure	5.37e-11	605
developing anatomical structure	5.37e-11	605
germ layer	1.16e-10	604
embryonic tissue	1.16e-10	604
presumptive structure	1.16e-10	604
epiblast (generic)	1.16e-10	604
hematopoietic system	1.20e-10	102
blood island	1.20e-10	102
anterior neural tube	1.46e-10	42
hemolymphoid system	2.57e-10	112
regional part of forebrain	5.81e-10	41
forebrain	5.81e-10	41
future forebrain	5.81e-10	41
regional part of brain	1.01e-09	59
regional part of nervous system	1.97e-09	94
nervous system	1.97e-09	94
pre-chordal neural plate	4.73e-09	61
central nervous system	7.88e-09	82
telencephalon	5.85e-08	34
gray matter	5.87e-08	34
brain grey matter	5.87e-08	34
bone marrow	7.19e-08	80
brain	9.76e-08	69
future brain	9.76e-08	69
regional part of telencephalon	9.99e-08	33
bone element	1.14e-07	86
anterior region of body	3.23e-07	129
craniocervical region	3.23e-07	129
cerebral hemisphere	4.29e-07	32
immune system	7.40e-07	115

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.